Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Roche identifies new DPP-IV inhibitors

Sep. 15, 2003

NDA filed for cinacalcet hydrochloride

Sep. 12, 2003

SBIR grant supports BioSante's oral insulin development efforts

Sep. 12, 2003

Improved glycemic control associated with exenatide in diabetes

Sep. 12, 2003

Takeda acquires Japanese rights to antiobesity drug candidate ATL-962

Sep. 12, 2003

Beneficial effects described for NN-2211 in the treatment of type 2 diabetes

Sep. 12, 2003

Long-term phase I/II data support use of I2S for Hunter's syndrome

Sep. 10, 2003

Neurocrine patent covers series of pyrrole-based melanocortin receptor modulators

Sep. 10, 2003

Novel cathepsin K inhibitors under study at Aventis

Sep. 10, 2003

Metabolic disease treatments to be developed under Amgen/Biovitrum collaboration

Sep. 9, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...